Provide cancer patients with personalized precision testing services and one-stop solution for cancer management
Provide patients suffering from rare diseases with molecular diagnostics & genetic screening services
Provide highly-personalized and systematic health management services for people with particularly high risks
Provide high-quality & fully-customizable scientific research services for our domestic/international partners
Geneseeq has been committed to the clinical translational reseach of Next-Generation Sequencing (NGS) in the field of cancer precision medicine since 2008. Geneseeq has established a large NGS cancer genomic database in China (>180,000 samples).